26 April 2017
News and Views
Links and Services
March's issue of the Clinical Gastroenterology & Hepatology reviews bisphosphonates are associated with reduced risk of colorectal cancer.
Colorectal cancer is the third most common cancer worldwide.
Several preclinical and obser
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors